Customer-centric marketing: changing demands

Chairman’s introduction: Seismic shifts in the European pharma industry

• Are they real?
• What are the implications for marketing?
• How do you stay standing!

Roland Powell
Independent consultant

Recently European Director of Marketing & Sales Capabilities
Recently Eli Lilly

How quickly does our current business model need to change? Are you keeping up?

• Who is the real customer?
• Find out what the customer wants and how we can we give it to them
• What are our options for tomorrow?

Erik Nordkamp
European Director Transformation, Six Sigma and Capabilities
Eli Lilly

How does eMarketing fit in the pharma big-picture?

• Understand how it will affect the industry and how you can respond effectively
• Find out what it will mean for corporate structures and careers and how you can prepare now
• Will eMarketing replace sales reps and become the central pillar of the marketing mix?

Kathleen Onieal
Formally VP Marketing Innovation at MSD

Think people not patients

• Find out how both RX and OTC can look into consumers' needs and better communicate medical benefits
• Discover how major pharmacist chains dominate the future of the changing European environment
• Learn why more indications are likely to become OTC to strengthen 'consumer self care'
• Understand the implications of all this for marketing strategy

Petra Meyer
VP Global Marketing
Merck Consumer Healthcare

Pharma 2021: the next generation of Marketing

• Learn how pharma marketing got to its current position and where it will go
• Understand the strategic options available to you and your company
• Explore the potential solutions to address the predicament and improve ROI

Nick O'Hare
Senior Consultant
PricewaterhouseCoopers

Interactive Workshop: Value Innovation for Pharma – What changes to business?

• Understand how the Pharma Industry needs to differentiate in advanced market conditions. Innovating value to customers (health care professionals) and to consumers (patients) can create sustainable performance.
• Find out how the new ways of market access - account focus, multichannel management, CRM and e-communication, commercial processes for differentiated accounts - will challenge pharma to innovate. Learn how product marketing will integrate with the portfolio and the company‘s proposition and what the implications will be to the organisation
• Discover what changes will be effective and efficient and whether there really
  is a need to change the business model of Pharma. Find out how those
  changes can be implemented without putting performance at risk

Rob Halkes
Van Spaendonck Management Consultants - Workshop sponsor